Journal of Ophthalmology

Journal of Ophthalmology / 2018 / Article

Corrigendum | Open Access

Volume 2018 |Article ID 9171269 | 2 pages | https://doi.org/10.1155/2018/9171269

Corrigendum to “Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab”

Received24 Apr 2018
Accepted27 May 2018
Published08 Jul 2018

In the article titled “Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab” [1], there were errors, which should be corrected as follows:(i)In Abstract, the term “(DEP)” should be “(PED).”(ii)In Results, “Change of CRT did not reach the significant difference at any time point of the study (M6: 312 ± 91 µm, NS; M12: 312 ± 84 µm, NS; M24: 312 ± 12.3, NS)” should be corrected to “Change of CRT did not reach the significant difference at any time point of the study (M6: 312 ± 14 µm, NS; M12: 313 ± 13.9 µm, NS; M24: 305 ± 76, NS).”(iii)In Table 2, there were errors in the values in the third, fourth, and sixth columns. The corrected table and its description are shown below.


Central macular thickness (µm)BaselineMonth 3Month 6Month 12Month 24

ETDRS64.4 ± 13.167.6 ± 12.30.00267.3 ± 110.00564.8 ± 130.661.4 ± 13.80.2
Central macular thickness (µm)313 ± 13301 ± 770.2312 ± 14.20.9313 ± 13.90.9305 ± 760.6
Macular volume (mm3)7.70 ± 2.27.75 ± 0.160.87.8 ± 0.160.67.85 ± 0.160.47.8 ± 0.650.3
PED height (µm)224.7 ± 18.5198.5 ± 19.50.025190 ± 17.30.05224 ± 210.27200 ± 190.14
Subfoveal choroidal thickness (µm)179 ± 68158 ± 670.2174 ± 560.5

Data are mean  ±  SD unless indicated otherwise. : continuous variables compared by independent samples t-test from baseline; ETDRS: Early Treatment Diabetic Retinopathy Score; PED: pigment epithelial detachment.

References

  1. T. H. C. Tran, S. Dumas, and F. Coscas, “Two-year outcome of aflibercept in patients with pigment epithelial detachment due to neovascular age-related macular degeneration (nAMD) refractory to ranibizumab,” Journal of Ophthalmology, vol. 2017, Article ID 8984313, 8 pages, 2017. View at: Publisher Site | Google Scholar

Copyright © 2018 Thi Ha Chau Tran et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

392 Views | 227 Downloads | 1 Citation
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.